DALLAS — Compared with standard of care tests and most clinical signs, the molecular bacterial load assay demonstrated higher sensitivity and more rapid turnaround times for monitoring tuberculosis (TB) treatment, according to study results presented at the American Thoracic Society International Conference held May 17-22, in Dallas, Texas.
